Cargando…
A cost–benefit analysis of COVID-19 lockdowns in Australia
This paper conducts a cost–benefit analysis of Australia’s Covid-19 lockdown strategy relative to pursuit of a mitigation strategy in March 2020. The estimated additional deaths from a mitigation strategy are 11,500 to 40,000, implying a Cost per Quality Adjusted Life Year saved by locking down of a...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794621/ https://www.ncbi.nlm.nih.gov/pubmed/35088370 http://dx.doi.org/10.1007/s40592-021-00148-y |
_version_ | 1784640854329131008 |
---|---|
author | Lally, Martin |
author_facet | Lally, Martin |
author_sort | Lally, Martin |
collection | PubMed |
description | This paper conducts a cost–benefit analysis of Australia’s Covid-19 lockdown strategy relative to pursuit of a mitigation strategy in March 2020. The estimated additional deaths from a mitigation strategy are 11,500 to 40,000, implying a Cost per Quality Adjusted Life Year saved by locking down of at least 11 times the generally employed figure of $100,000 for health interventions in Australia. The lockdowns do not then seem to have been justified by reference to the standard benchmark. Consideration of the information available to the Australian government in March 2020 yields a similar ratio and therefore the same conclusion that lockdown was not warranted. If Australia experiences a new outbreak, and cannot contain it without resort to a nationwide lockdown, the death toll from adopting a mitigation strategy at this point would be even less than had it done so in March 2020, due to the vaccination campaign, lessons learned since March 2020, and because the period over which the virus would then inflict casualties would now be much less than the period from March 2020. This would favour a mitigation policy even more strongly than in March 2020. This approach of assessing the savings in quality adjusted life years and comparing them to a standard benchmark figure ensures that all quality adjusted life years saved by various health interventions are treated equally, which accords with the ethical principle of equity across people. |
format | Online Article Text |
id | pubmed-8794621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-87946212022-01-28 A cost–benefit analysis of COVID-19 lockdowns in Australia Lally, Martin Monash Bioeth Rev Original Article This paper conducts a cost–benefit analysis of Australia’s Covid-19 lockdown strategy relative to pursuit of a mitigation strategy in March 2020. The estimated additional deaths from a mitigation strategy are 11,500 to 40,000, implying a Cost per Quality Adjusted Life Year saved by locking down of at least 11 times the generally employed figure of $100,000 for health interventions in Australia. The lockdowns do not then seem to have been justified by reference to the standard benchmark. Consideration of the information available to the Australian government in March 2020 yields a similar ratio and therefore the same conclusion that lockdown was not warranted. If Australia experiences a new outbreak, and cannot contain it without resort to a nationwide lockdown, the death toll from adopting a mitigation strategy at this point would be even less than had it done so in March 2020, due to the vaccination campaign, lessons learned since March 2020, and because the period over which the virus would then inflict casualties would now be much less than the period from March 2020. This would favour a mitigation policy even more strongly than in March 2020. This approach of assessing the savings in quality adjusted life years and comparing them to a standard benchmark figure ensures that all quality adjusted life years saved by various health interventions are treated equally, which accords with the ethical principle of equity across people. Springer International Publishing 2022-01-28 2022 /pmc/articles/PMC8794621/ /pubmed/35088370 http://dx.doi.org/10.1007/s40592-021-00148-y Text en © Monash University 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Lally, Martin A cost–benefit analysis of COVID-19 lockdowns in Australia |
title | A cost–benefit analysis of COVID-19 lockdowns in Australia |
title_full | A cost–benefit analysis of COVID-19 lockdowns in Australia |
title_fullStr | A cost–benefit analysis of COVID-19 lockdowns in Australia |
title_full_unstemmed | A cost–benefit analysis of COVID-19 lockdowns in Australia |
title_short | A cost–benefit analysis of COVID-19 lockdowns in Australia |
title_sort | cost–benefit analysis of covid-19 lockdowns in australia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794621/ https://www.ncbi.nlm.nih.gov/pubmed/35088370 http://dx.doi.org/10.1007/s40592-021-00148-y |
work_keys_str_mv | AT lallymartin acostbenefitanalysisofcovid19lockdownsinaustralia AT lallymartin costbenefitanalysisofcovid19lockdownsinaustralia |